Novavax, Inc. (NASDAQ:NVAX) Most Promising Medical Research Stock, Shayne Heffernan Says

By HEFFX on June 11, 2020   2020, Coronavirus, Headline News, Health, Heffx Insights, Investments, MetaStock, Nasdaq, Opinion, Shayne Heffernan, Shayne Heffernan, Stocks, Todays Trade Ideas, Top Stories, US Stocks  

Novavax, Inc. (NASDAQ:NVAX) Most Promising Medical Research Stock, Shayne Heffernan Says A mix of legacy drug makers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus. NovavaxTicker: NASDAQ:NVAXPrice: $44.96 Novavax Inc. US:NVAX, a preclinical biotechnology company, announced Feb. 26 that it had […]